Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we talk about the FDA’s new artificial intelligence effort in the wake of mass layoffs, see AI darling Insitro cut s...
| Details | Interest | Feed |
| Details | Interest | Feed |
Origin
www.statnews.com
May 9, 2025 at 1:24 PM
📢 Insitro is #hiring a Manager / Associate Director, Laboratory Operations and Materials Management!
💰 $125K - $165K
📍 San Francisco, CA
🔗 http://jbs.ink/nYS0uwZ1lUg4
#remotejob #remotework #wfh
💰 $125K - $165K
📍 San Francisco, CA
🔗 http://jbs.ink/nYS0uwZ1lUg4
#remotejob #remotework #wfh
December 15, 2024 at 4:16 PM
📢 Insitro is #hiring a Manager / Associate Director, Laboratory Operations and Materials Management!
💰 $125K - $165K
📍 San Francisco, CA
🔗 http://jbs.ink/nYS0uwZ1lUg4
#remotejob #remotework #wfh
💰 $125K - $165K
📍 San Francisco, CA
🔗 http://jbs.ink/nYS0uwZ1lUg4
#remotejob #remotework #wfh
This was a fun collaboration with my colleagues at insitro and I hope it will be useful to researchers who are considering the use of ML based imputation of phenotypes for GWAS. More details in the pre-print: www.biorxiv.org/content/10.1...
Causal considerations can determine the utility of machine learning assisted GWAS
Machine Learning (ML) is increasingly employed to generate phenotypes for genetic discovery, either by imputing existing phenotypes into larger cohorts or by creating novel phenotypes. While these ML-...
www.biorxiv.org
December 17, 2024 at 6:08 PM
This was a fun collaboration with my colleagues at insitro and I hope it will be useful to researchers who are considering the use of ML based imputation of phenotypes for GWAS. More details in the pre-print: www.biorxiv.org/content/10.1...
Check out this event at the BioScience Forum: Philip Tagari, CSO of insitro, Feb 19th, 5-8 pm in SSF. Accelerating drug discovery by applying machine learning and generative AI.
Registration: biosf.org #drugdiscovery #biotech #AI #machinelearning #insitro #biotechnoloogy #drugdiscovery
Registration: biosf.org #drugdiscovery #biotech #AI #machinelearning #insitro #biotechnoloogy #drugdiscovery
Home - BioScience Forum
biosf.org
January 16, 2025 at 3:26 AM
Check out this event at the BioScience Forum: Philip Tagari, CSO of insitro, Feb 19th, 5-8 pm in SSF. Accelerating drug discovery by applying machine learning and generative AI.
Registration: biosf.org #drugdiscovery #biotech #AI #machinelearning #insitro #biotechnoloogy #drugdiscovery
Registration: biosf.org #drugdiscovery #biotech #AI #machinelearning #insitro #biotechnoloogy #drugdiscovery
Missed the SBI2 conference last year?
Here is your chance to watch the 2024 keynote from Daphne Koller from Insitro
➡️ Head over to sbi2.org/education/
Here is your chance to watch the 2024 keynote from Daphne Koller from Insitro
➡️ Head over to sbi2.org/education/
Education - The Society of Biomolecular Imaging and Informatics
Education Materials Recorded Presentations from SBI2 Conferences Educational Sessions Special Colloquium: Podium Presentations Introductory Material and Best Practices in High-Content Imaging…
sbi2.org
May 1, 2025 at 12:33 PM
Missed the SBI2 conference last year?
Here is your chance to watch the 2024 keynote from Daphne Koller from Insitro
➡️ Head over to sbi2.org/education/
Here is your chance to watch the 2024 keynote from Daphne Koller from Insitro
➡️ Head over to sbi2.org/education/
🚨 LAYOFF ALERT - California 🇺🇸
Insitro, AI-driven biotech firm will layoff 22% of employees(~60 employees) to conserve resources for clinical trials amid broader biotech downturn.
Insitro, AI-driven biotech firm will layoff 22% of employees(~60 employees) to conserve resources for clinical trials amid broader biotech downturn.
May 9, 2025 at 3:21 PM
🚨 LAYOFF ALERT - California 🇺🇸
Insitro, AI-driven biotech firm will layoff 22% of employees(~60 employees) to conserve resources for clinical trials amid broader biotech downturn.
Insitro, AI-driven biotech firm will layoff 22% of employees(~60 employees) to conserve resources for clinical trials amid broader biotech downturn.
Exclusive: Insitro makes headway on the harder road, discovering new ALS drug target
CEO Daphne Koller shared with me the biotech's first progress update on a 2020 Bristol Myers collab on ALS & dementia.
More details here in my latest for @endpts.com:
endpts.com/exclusive-in...
CEO Daphne Koller shared with me the biotech's first progress update on a 2020 Bristol Myers collab on ALS & dementia.
More details here in my latest for @endpts.com:
endpts.com/exclusive-in...
Exclusive: Insitro makes headway on the harder road, discovering new ALS drug target
The AI-focused biotech insitro is advancing a new idea to potentially treat ALS, one of the most intractable and brutal diseases. The South San Francisco-based startup has identified a new ...
endpts.com
December 18, 2024 at 1:11 PM
Exclusive: Insitro makes headway on the harder road, discovering new ALS drug target
CEO Daphne Koller shared with me the biotech's first progress update on a 2020 Bristol Myers collab on ALS & dementia.
More details here in my latest for @endpts.com:
endpts.com/exclusive-in...
CEO Daphne Koller shared with me the biotech's first progress update on a 2020 Bristol Myers collab on ALS & dementia.
More details here in my latest for @endpts.com:
endpts.com/exclusive-in...
AI is transforming industries, yet pharma still needs to work on developing drugs faster. Insitro, founded in 2018, uses AI to speed drug discovery. Partnering with Eli Lilly and Bristol Myers, it aims to tackle diseases. CEO Daphne Koller discusses AI's role in drug development with AP
#AI #Biotech
#AI #Biotech
Better drugs through AI? Insitro CEO on what machine learning can teach Big Pharma
Artificial intelligence is changing the way industries do business. But executives in the pharmaceutical industry are still waiting to see whether AI can tackle their biggest challenge: finding faster...
apnews.com
December 3, 2024 at 5:44 PM
$BMY: Bristol Myers Squibb is also collaborating with Insitro, indicating a strategic move towards leveraging AI for drug discovery. Successful outcomes from this partnership could enhance the company's pipeline and market position.
December 2, 2024 at 7:22 PM
$BMY: Bristol Myers Squibb is also collaborating with Insitro, indicating a strategic move towards leveraging AI for drug discovery. Successful outcomes from this partnership could enhance the company's pipeline and market position.
In this episode of JAMA+ AI Conversations, Editor in Chief Roy Perlis interviews Ajamete Kaykas, Chief eXploration Officer at insitro, a biotech company looking to apply AI to develop new therapeutics. ja.ma/3XeCLVW ja.ma/3XeCLVW
https://ja.ma/4qLWiKT
AI for Drug Discovery
ja.ma
November 6, 2025 at 5:00 PM
In this episode of JAMA+ AI Conversations, Editor in Chief Roy Perlis interviews Ajamete Kaykas, Chief eXploration Officer at insitro, a biotech company looking to apply AI to develop new therapeutics. ja.ma/3XeCLVW ja.ma/3XeCLVW
insitro Receives $25 Million in Milestone Payments from Bristol Myers Squibb for the Achievement of Discovery Milestones and the Selection of First Novel Genetic Target for ALS
www.businesswire.com/news/home/20...
www.businesswire.com/news/home/20...
insitro Receives $25 Million in Milestone Payments from Bristol Myers Squibb for the Achievement of Discovery Milestones and the Selection of First Novel Genetic Target for ALS
insitro, a machine learning-enabled drug discovery and development company, today announced it has received $25 million from Bristol Myers Squibb (NYS
www.businesswire.com
December 18, 2024 at 9:08 PM
insitro Receives $25 Million in Milestone Payments from Bristol Myers Squibb for the Achievement of Discovery Milestones and the Selection of First Novel Genetic Target for ALS
www.businesswire.com/news/home/20...
www.businesswire.com/news/home/20...
@Forbes: "If we go back a year ago, we would not have predicted where we are today [with AI]."
@DaphneKoller, CEO and founder of @insitro, joined @morgancheatham to discuss building the next generation of AI companies at the 2023 #ForbesHealth Summit. https://t.co/a3U5y5GBXT https://t.co/Hd0Qz5WaDT
@DaphneKoller, CEO and founder of @insitro, joined @morgancheatham to discuss building the next generation of AI companies at the 2023 #ForbesHealth Summit. https://t.co/a3U5y5GBXT https://t.co/Hd0Qz5WaDT
December 5, 2023 at 4:56 PM
@Forbes: "If we go back a year ago, we would not have predicted where we are today [with AI]."
@DaphneKoller, CEO and founder of @insitro, joined @morgancheatham to discuss building the next generation of AI companies at the 2023 #ForbesHealth Summit. https://t.co/a3U5y5GBXT https://t.co/Hd0Qz5WaDT
@DaphneKoller, CEO and founder of @insitro, joined @morgancheatham to discuss building the next generation of AI companies at the 2023 #ForbesHealth Summit. https://t.co/a3U5y5GBXT https://t.co/Hd0Qz5WaDT
Early May delivered another biotech layoff squeeze: Insitro (-22 %), Korro (-20 %), RallyBio (-40 %), Mersana (-55 %), Pliant (-45 %), Biomea (-35 %), Mammoth (-24 %) and Bristol Myers Squibb (516 jobs) all slashed staff. All moves aim to extend cash runways or refocus pipelines.
May 9, 2025 at 4:12 PM
Early May delivered another biotech layoff squeeze: Insitro (-22 %), Korro (-20 %), RallyBio (-40 %), Mersana (-55 %), Pliant (-45 %), Biomea (-35 %), Mammoth (-24 %) and Bristol Myers Squibb (516 jobs) all slashed staff. All moves aim to extend cash runways or refocus pipelines.
2012년 동료 스탠포드 학자인 앤드류 응과 함께 교육플랫폼인 Coursera를 창립했습니다.
2016년 이 회사를 떠나 칼리코의 Chief Computer Officer였다가 2018년 신약 발견 스타트업 회사인 Insitro에 들어갔습니다.
94년 아서 새뮤얼 논문상을 수상했습니다
96년 슬론 재단 교직원상
98년 해군 연구국 젊은 연구자상
99년 대통령이 수상하는 젊은 과학자,공학자상
2016년 이 회사를 떠나 칼리코의 Chief Computer Officer였다가 2018년 신약 발견 스타트업 회사인 Insitro에 들어갔습니다.
94년 아서 새뮤얼 논문상을 수상했습니다
96년 슬론 재단 교직원상
98년 해군 연구국 젊은 연구자상
99년 대통령이 수상하는 젊은 과학자,공학자상
August 26, 2025 at 3:00 PM
2012년 동료 스탠포드 학자인 앤드류 응과 함께 교육플랫폼인 Coursera를 창립했습니다.
2016년 이 회사를 떠나 칼리코의 Chief Computer Officer였다가 2018년 신약 발견 스타트업 회사인 Insitro에 들어갔습니다.
94년 아서 새뮤얼 논문상을 수상했습니다
96년 슬론 재단 교직원상
98년 해군 연구국 젊은 연구자상
99년 대통령이 수상하는 젊은 과학자,공학자상
2016년 이 회사를 떠나 칼리코의 Chief Computer Officer였다가 2018년 신약 발견 스타트업 회사인 Insitro에 들어갔습니다.
94년 아서 새뮤얼 논문상을 수상했습니다
96년 슬론 재단 교직원상
98년 해군 연구국 젊은 연구자상
99년 대통령이 수상하는 젊은 과학자,공학자상
This work was led by our very capable intern Suma Anand, a PhD student at UC Berkeley and conducted in collaboration with Kaiwen Xu and Colm O'Dushlaine, with support from many others at Insitro. (end)
November 18, 2024 at 4:54 AM
This work was led by our very capable intern Suma Anand, a PhD student at UC Berkeley and conducted in collaboration with Kaiwen Xu and Colm O'Dushlaine, with support from many others at Insitro. (end)
Founder Stories: Daphne Koller, Founder and CEO of Insitro youtu.be/_R_PHn-gKFc
September 3, 2023 at 3:46 PM
Founder Stories: Daphne Koller, Founder and CEO of Insitro youtu.be/_R_PHn-gKFc
Eli Lilly offers free access to its AI models for small biotech firms! How will this impact drug development? #BiotechInnovation
https://www.statnews.com/2025/09/09/eli-lilly-ai-tunelab-biotech-drug-insitro/
https://www.statnews.com/2025/09/09/eli-lilly-ai-tunelab-biotech-drug-insitro/
Lilly will let small biotechs use its AI models at no cost
Lilly is opening up its proprietary AI models to biotech companies that want to use them to jumpstart their science.
www.statnews.com
September 9, 2025 at 8:52 PM
Eli Lilly offers free access to its AI models for small biotech firms! How will this impact drug development? #BiotechInnovation
https://www.statnews.com/2025/09/09/eli-lilly-ai-tunelab-biotech-drug-insitro/
https://www.statnews.com/2025/09/09/eli-lilly-ai-tunelab-biotech-drug-insitro/
Join us June 17–18 at UCSF for “Separating the Signal from the Noise: AI in Biology” — a 2-day symposium with speakers from Google, Genentech, Insitro, MIT, Freie Universität Berlin, CZI, University of Toronto, Alberta Machine Intelligence Institute, QBI UCSF, and Rezo!
qbi.ucsf.edu/ai-symposium...
qbi.ucsf.edu/ai-symposium...
May 30, 2025 at 9:06 PM
Join us June 17–18 at UCSF for “Separating the Signal from the Noise: AI in Biology” — a 2-day symposium with speakers from Google, Genentech, Insitro, MIT, Freie Universität Berlin, CZI, University of Toronto, Alberta Machine Intelligence Institute, QBI UCSF, and Rezo!
qbi.ucsf.edu/ai-symposium...
qbi.ucsf.edu/ai-symposium...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we talk about the FDA’s new artificial intelligence effort in the wake of mass layoffs, see AI darling Insitro cut s...
| Details | Interest | Feed |
| Details | Interest | Feed |
Origin
www.statnews.com
May 12, 2025 at 2:01 PM
"With insitro,we are also using a novel, AI/ML-enabled technology called Pooled Optical Screening in Human Cells to identify genes that modify neurodegenerative diseases. Thru this collaboration,we are discovering novel targets that could be used to develop treatments for diseases w/ high unmet need
January 23, 2025 at 6:51 PM
"With insitro,we are also using a novel, AI/ML-enabled technology called Pooled Optical Screening in Human Cells to identify genes that modify neurodegenerative diseases. Thru this collaboration,we are discovering novel targets that could be used to develop treatments for diseases w/ high unmet need
COAST-SS is available in an updated AllelicSeries R package (github.com/insitro/Alle...). Congrats to all coauthors @zmccaw.bsky.social, Jianhui Gao, Rounak Dey, Simon Tucker, Yiyan Zhang, Jessica Gronsbell, Xihao Li, Emily Fox, @codushlaine.bsky.social and the Research Team @insitro.bsky.social!
GitHub - insitro/AllelicSeries: Implementation of gene-level rare coding variant association tests targeting allelic series: cases where increasingly deleterious mutations have increasingly large phen...
Implementation of gene-level rare coding variant association tests targeting allelic series: cases where increasingly deleterious mutations have increasingly large phenotypic effects. - insitro/All...
github.com
October 18, 2025 at 12:01 PM
COAST-SS is available in an updated AllelicSeries R package (github.com/insitro/Alle...). Congrats to all coauthors @zmccaw.bsky.social, Jianhui Gao, Rounak Dey, Simon Tucker, Yiyan Zhang, Jessica Gronsbell, Xihao Li, Emily Fox, @codushlaine.bsky.social and the Research Team @insitro.bsky.social!
I: TechBio Latest Summer News & Updates
Trends on TechBio ⛽: Lantern, Asimov, Scriptome, Insitro, Xtalpi (Ailux), Eurofins, Basecamp, X-Chem, Verseon and Top 10 Swiss AI Healthcare Startups
open.substack.com/pub/marinata...
#drugdiscovery #AI
#biotech
#metaphysicalcells
#substack
#techbio
Trends on TechBio ⛽: Lantern, Asimov, Scriptome, Insitro, Xtalpi (Ailux), Eurofins, Basecamp, X-Chem, Verseon and Top 10 Swiss AI Healthcare Startups
open.substack.com/pub/marinata...
#drugdiscovery #AI
#biotech
#metaphysicalcells
#substack
#techbio
I: TechBio Latest Summer News & Updates
Trends on TechBio ⛽: Lantern, Asimov, Scriptome, Insitro, Xtalpi (Ailux), Eurofins, Basecamp, X-Chem, Verseon and Top 10 Swiss AI Healthcare Startups
open.substack.com
December 3, 2024 at 2:50 PM
I: TechBio Latest Summer News & Updates
Trends on TechBio ⛽: Lantern, Asimov, Scriptome, Insitro, Xtalpi (Ailux), Eurofins, Basecamp, X-Chem, Verseon and Top 10 Swiss AI Healthcare Startups
open.substack.com/pub/marinata...
#drugdiscovery #AI
#biotech
#metaphysicalcells
#substack
#techbio
Trends on TechBio ⛽: Lantern, Asimov, Scriptome, Insitro, Xtalpi (Ailux), Eurofins, Basecamp, X-Chem, Verseon and Top 10 Swiss AI Healthcare Startups
open.substack.com/pub/marinata...
#drugdiscovery #AI
#biotech
#metaphysicalcells
#substack
#techbio
I was reading books like “On Tyranny” by Timothy Snyder who now also works at @uoft.bsky.social How about moving inSitro, the entire company, here?
April 5, 2025 at 11:13 AM
I was reading books like “On Tyranny” by Timothy Snyder who now also works at @uoft.bsky.social How about moving inSitro, the entire company, here?
On BMS's collaboration w/ insitro, Plenge said: "we are leveraging AI/ML-powered phenotypic screens using induced pluripotent stem cell (iPSC)-derived disease models for neurodegenerative disorders. Neurodegenerative diseases often have heterogeneous genetic causes, but the 1/n #biosky
Bristol Myers Squibb's Chief Research Officer/EVP Robert Plenge posted about their Research organization’s AI/ML strategy & capabilities to solve complex biological problems.#biosky :"We now have AI/ML capabilities that have been trained on millions of www.plengegen.com/blog/ai-sequ... 1/n
January 23, 2025 at 6:51 PM
On BMS's collaboration w/ insitro, Plenge said: "we are leveraging AI/ML-powered phenotypic screens using induced pluripotent stem cell (iPSC)-derived disease models for neurodegenerative disorders. Neurodegenerative diseases often have heterogeneous genetic causes, but the 1/n #biosky